PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
| Image |  |
|---|---|
| Description | scientific article published on 7 February 2018 |
| Author/s |
author: Xiaochang Xue |
| Publication date | February 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |